Documents
Application Sponsors
BLA 761173 | FRESENIUS KABI USA | |
Marketing Status
Application Products
001 | SOLUTION; INJECTION | 6MG/0.6ML | 0 | STIMUFEND | PEGFILGRASTIM-FPGK |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2022-09-01 | STANDARD |
Submissions Property Types
CDER Filings
FRESENIUS KABI USA
cder:Array
(
[0] => Array
(
[ApplNo] => 761173
[companyName] => FRESENIUS KABI USA
[docInserts] => ["",""]
[products] => [{"drugName":"STIMUFEND","activeIngredients":"PEGFILGRASTIM-FPGK","strength":"6MG\/0.6ML","dosageForm":"SOLUTION; INJECTION","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"09\/01\/2022","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/761173s000lbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"09\/01\/2022","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"N\/A","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2022\\\/761173s000lbl.pdf\"},{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2022\\\/761173Orig1s000ltr.pdf\"}]","notes":">"}]
[supplements] =>
[actionDate] => 2022-09-01
)
)